相关实验视频
Updated: Jul 11, 2025

07:32
Assessment of Vascular Regeneration in the CNS Using the Mouse Retina
Published on: June 23, 2014
14.5K
治疗中枢神经系统初级血管炎的治疗方法
1Medicine Department, University of Washington, MS 359860, 325 9th Avenue, Seattle, WA 98104, USA.
Neuroimaging clinics of North America
|November 11, 2023
概括
主要中枢神经系统血管炎 (PCNSV) 是一种罕见的疾病,影响大脑和脊髓. 治疗包括类固醇和免疫抑制剂,对于复发或耐药病例,有替代药物,如rituximab.
科学领域:
- 神经学 神经学
- 免疫学 免疫学 免疫学
- 类风湿病学 类风湿病学
背景情况:
- 主要中枢神经系统血管炎 (PCNSV) 是一种仅影响大脑和脊髓的炎症性疾病.
- 由于PCNSV的罕见性和可能导致严重的神经缺陷,PCNSV的诊断和管理存在重大临床挑战.
研究的目的:
- 审查目前对初级中枢神经系统血管炎 (PCNSV) 的理解.
- 概述PCNSV管理的既定和替代治疗策略.
- 讨论PCNSV治疗反应和疾病复发的影响.
主要方法:
- 关于初级中枢神经系统血管炎 (PCNSV) 治疗方案的文献综述.
- 诱导和维持治疗方案的分析,包括类固醇和免疫抑制剂.
- 对抗性或复发性PCNSV的替代治疗方法,如rituximab和mycophenolate mofetil的评估.
主要成果:
- 对PCNSV的标准诱导疗法通常涉及类固醇和环胺.
- 维护疗法通常包括普雷迪尼松缩小剂,可能与阿扎西奥普林或mycophenolate mofetil.
- 利图西马布和mycophenolate mofetil显示为对治疗耐药性或疾病复发患者的替代方案的承诺.
结论:
- 有效管理PCNSV需要一个量身定制的诱导和维持治疗方法.
- 替代性免疫抑制剂对于患有复发或对初始治疗反应不足的患者至关重要.
- 了解治疗结果和死亡率 (8-9%) 对于管理PCNSV患者至关重要.
更多相关视频
相关概念视频
Alzheimer's Disease: Treatment
197
Alzheimer's Disease (AD), a neurodegenerative disorder, is pathologically identified by amyloid plaques and neurofibrillary tangles composed of tau protein. AD pharmacotherapy aims to manage cognitive symptoms, delay disease progression, and treat behavioral symptoms. The treatment is primarily symptomatic and palliative, with no definitive disease-modifying therapy available. Cholinesterase inhibitors, including donepezil (Aricept), rivastigmine (Exelon), and galantamine (Razadyne), are...
197
Peripheral Artery Disease III: Interprofessional Care
11
Peripheral Artery Disease (PAD) is characterized by narrowed arteries that diminish blood flow to the extremities. Effective management of PAD requires an interprofessional approach involving various healthcare professionals. The critical aspects of interprofessional care for PAD patients focus on risk factor modification, drug therapy, exercise therapy, nutrition therapy, critical limb ischemia care, and interventional radiology and surgical procedures.The primary treatment goal for PAD...
11
Myasthenia Gravis: Overview and Treatment
1.5K
Myasthenia gravis is a neuromuscular transmission disorder characterized by weakness and increased fatigability of skeletal muscles. It is an autoimmune disease affecting approximately one in 2000 people, where antibodies against the α1 subunit of nicotinic acetylcholine receptors are produced.
These antibodies interfere with the function of the nicotinic receptors in three ways: by binding to the receptor and disrupting acetylcholine binding; by causing cross-linking of receptors which...
These antibodies interfere with the function of the nicotinic receptors in three ways: by binding to the receptor and disrupting acetylcholine binding; by causing cross-linking of receptors which...
1.5K
Open Angle Glaucoma: Treatment
459
In open-angle glaucoma, the iridocorneal angle remains open, but the trabecular meshwork becomes stiff, slowing down the outflow of aqueous humor. This causes a buildup of aqueous humor in the anterior chamber, leading to a sudden increase in intraocular pressure. The treatment for open-angle glaucoma focuses on reducing the elevated intraocular pressure by either decreasing the secretion of aqueous humor or increasing its outflow.
Drugs such as carbonic anhydrase inhibitors, α2- and...
Drugs such as carbonic anhydrase inhibitors, α2- and...
459
Angle Closure Glaucoma: Treatment
534
Angle-closure glaucoma, or closed-angle glaucoma, is an eye condition where the iris bulges out and blocks the iridocorneal angle, resulting in a buildup of aqueous humor and increased intraocular pressure. Immediate medical attention is necessary due to the sudden onset of symptoms. The treatment for angle-closure glaucoma includes short-term and long-term approaches. Short-term treatment involves using eye drops like pilocarpine to lower intraocular pressure by increasing aqueous humor...
534

